N
Live / Applied — First extension granted (statement of use) (as of 10 Sept 2026)
What this means for you
Not registered yet, but its 30 Jul 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99311327
- Mark type
- Design + words
- Filed
- 30 Jul 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Aaron W. Pederson
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical, biologic, and vaccine research and development; consulting services in the field of research and development of pharmaceutical, biologic, and vaccine preparations and adjuvants; providing medical and scientific research information in the field of pharmaceuticals, biologics, vaccines, and clinical trials and post-market trials related to pharmaceuticals, biologics, and vaccines
Owner
- Novavax, Inc., Gaithersburg, MD, US
- Novavax, Inc., Gaithersburg, MD, US
Prosecution history
- 11 Sept 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Sept 2026 — SOU EXTENSION 1 GRANTED
- 10 Sept 2026 — SOU EXTENSION 1 FILED
- 10 Sept 2026 — SOU TEAS EXTENSION RECEIVED
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 15 Dec 2025 — ASSIGNED TO EXAMINER
- 08 Dec 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 08 Dec 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 30 Jul 2025 — APPLICATION FILING RECEIPT MAILED
- 30 Jul 2025 — NEW APPLICATION ENTERED